HLA-G and graft versus host disease: For the above available data along with the proved transplantation tolerance induced by HLA-G and the relationship between HLA-G levels and GVHD, therapeutic HLA-G molecules have been proposed as a promising and ideal biologic immunosuppression candidate for clinical use to the prevention and treatment of GVHD.